TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16301500

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study: 12145556

Group type: EXPERIMENTAL
Intervention: Multi-antioxidant supplementation (allopurinol, vitamins E and C, mannitol, N-acetylcysteine)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 42
Study: 9468207

Group type: EXPERIMENTAL
Intervention: Sibrafiban (5 mg daily to 10 mg twice daily for 28 days)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Sibrafiban (5 mg twice daily to 15 mg once daily for 28 days)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Sibrafiban (various doses)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Aspirin (for 28 days)
Number of subjects: 329
Study: 7892866

Group type: EXPERIMENTAL
Intervention: Antenatal steroids
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Cesarean section delivery with antenatal steroids
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Cesarean section delivery without antenatal steroids
Number of subjects: 505

Group type: COMPARATOR
Intervention: Vaginal delivery without antenatal steroids
Number of subjects: 505
Study: 2650470

Group type: EXPERIMENTAL
Intervention: Non-ionic contrast medium iohexol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ionic contrast medium diatrizoic acid
Number of subjects: 100
Study: 885711

Group type: EXPERIMENTAL
Intervention: 2% miconazole cream
Number of subjects: 84

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 84
Study: 30403966

Group type: EXPERIMENTAL
Intervention: Stylet slow‐pull‐back technique (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional negative suction after stylet removal (group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non‐suction after stylet removal (group C)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All techniques (group A, B, C)
Number of subjects: 50
Study: 29120912

Group type: EXPERIMENTAL
Intervention: 4-hour system-thinking program and a 2-hour simulation program
Number of subjects: 67

Group type: COMPARATOR
Intervention: 4-hour case study and a 2-hour simulation program
Number of subjects: 67
Study: 27560676

Group type: EXPERIMENTAL
Intervention: SRP + Er, Cr:YSGG laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 30
Study: 25043514

Group type: EXPERIMENTAL
Intervention: DHA+EPA (4 g/day)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: DHA enrichment
Number of subjects: 103
Study: 22317851

Group type: EXPERIMENTAL
Intervention: Infiltration of lidocaine plus 40 mg methylprednisolone acetate
Number of subjects: 58

Group type: COMPARATOR
Intervention: Xylocaine plus distilled water (placebo)
Number of subjects: 58
Study: 19875309

Group type: COMPARATOR
Intervention: Continuation of ramipril until the morning of surgery (Group B)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Continuation of ramipril until the morning of surgery and vasopressin infusion (Group C)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Discontinuation of ramipril 24 hours before surgery (Group A)
Number of subjects: 47
Study: 17828093

Group type: EXPERIMENTAL
Intervention: Gel Metrogil Denta and toothpaste Mexidol Dent aktiv
Number of subjects: 0
Study: 15642550

Group type: COMPARATOR
Intervention: gemfibrozil (1,200 mg/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: rosuvastatin (40 mg/day)
Number of subjects: 39
Study: 11792873

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunosuppressants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study: 10649916

Group type: EXPERIMENTAL
Intervention: Scotchbond 1 bonding system applied without prior acid-etching (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exposed sensitive roots acid-etched with 35% phosphoric acid for 15 seconds prior to bonding (Group 2)
Number of subjects: 30
Study: 7600776

Group type: EXPERIMENTAL
Intervention: Shampoo preserved with 15 ppm a.i. CMI/MI
Number of subjects: 27

Group type: COMPARATOR
Intervention: Shampoo preserved with 0.3% imidazolidinyl urea (IU)
Number of subjects: 27
Study: 2228058

Group type: EXPERIMENTAL
Intervention: Centperazine (300 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DEC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Centperazine
Number of subjects: 0
Study: 375449

Group type: EXPERIMENTAL
Intervention: Reserpine and kanamycin treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 54
Study: 31205182

Group type: EXPERIMENTAL
Intervention: Operative treatment (Op)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Nonoperative treatment (NonOp)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Incremental cost-effectiveness ratio (ICER) for Op compared to NonOp
Number of subjects: 95
Study: 28133931

Group type: EXPERIMENTAL
Intervention: Abatacept (10 mg/kg intravenously on days 1, 15, 29, and week 8)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Abatacept and Placebo
Number of subjects: 34
Study: 25623785

Group type: EXPERIMENTAL
Intervention: Intravenous lorazepam
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Intramuscular midazolam
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: ETI (any)
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Late ETI
Number of subjects: 1023
Study: 23711438

Group type: EXPERIMENTAL
Intervention: Tamsulosin HCl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 20646915

Group type: EXPERIMENTAL
Intervention: Hospital treatment
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Day hospital treatment
Number of subjects: 765
Study: 19283791

Group type: EXPERIMENTAL
Intervention: 2-year exercise program
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 51
Study: 17616536

Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate (FCA) 0.1 mg/d
Number of subjects: 21

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 21
Study: 15775731

Group type: EXPERIMENTAL
Intervention: Unopposed transdermal 17beta‐estradiol for 3 months
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Combination of unopposed transdermal 17beta‐estradiol and intermittent medroxyprogesterone acetate (MPA) after 12 months
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Unopposed transdermal 17beta‐estradiol and MPA
Number of subjects: 99

Group type: COMPARATOR
Intervention: HRT (Hormone Replacement Therapy)
Number of subjects: 99
Study: 12066081

Group type: EXPERIMENTAL
Intervention: Comfeel (Coloplast, UK)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granuflex improved formulation (Convatec, UK)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cutinova foam (Beiersdorf Medical, UK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 9532435

Group type: EXPERIMENTAL
Intervention: Cortical magnetic stimulation to the right hemisphere at a delay of 25 ms
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cortical magnetic stimulation to the left hemisphere at delays of 50 and 75 ms
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cortical magnetic stimulation (general)
Number of subjects: 5
Study: 7640157

Group type: EXPERIMENTAL
Intervention: Amoxycillin (broad spectrum antibiotic) administered for 2 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (not specified, but implied to be without antibiotic treatment)
Number of subjects: 10
Study: 2679220

Group type: EXPERIMENTAL
Intervention: Specific IgG antibodies
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-specific IgG
Number of subjects: 30
Study: 1087138

Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 26

Group type: COMPARATOR
Intervention: Combination chemotherapy
Number of subjects: 26
Study: 30219249

Group type: EXPERIMENTAL
Intervention: Supragingival scaling
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dental restoration under local anesthesia (LA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exodontia under local anesthesia (LA)
Number of subjects: 50
Study: 27929333

Group type: EXPERIMENTAL
Intervention: Self-regulation group (writing about deepest feelings and coping efforts)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Emotional disclosure group (writing about deepest thoughts and feelings)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Cancer-fact group (writing about facts relevant to cancer experience)
Number of subjects: 96
Study: 26474447

Group type: EXPERIMENTAL
Intervention: Personalized wellness program including a limited genetic profile, psychosocial assessment, and high-intensity coaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 23157935

Group type: EXPERIMENTAL
Intervention: DASH diet (4.1 g [105 mEq] potassium/2,100 kcal/d)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control diet (1.7 g [43 mEq] potassium/2,100 kcal/d)
Number of subjects: 412
Study: 21492728

Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 48

Group type: COMPARATOR
Intervention: External ventricular drainage (EVD)
Number of subjects: 48
Study: 19032700

Group type: EXPERIMENTAL
Intervention: Structured psychoeducational intervention (n = 38) consisting of monthly sessions for 9 months
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine out-patient care (n = 38) for the same duration
Number of subjects: 76
Study: 16409530

Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg/kg i.v. before induction of general anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ilioinguinal and iliohypogastric nerve block with 0.5% bupivacaine (0.25 ml/kg) before skin incision
Number of subjects: 60
Study: 14974267

Group type: EXPERIMENTAL
Intervention: New preparation for wound edge protection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 12964282

Group type: EXPERIMENTAL
Intervention: Allevyn (Smith and Nephew)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Biatain (Coloplast)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lyofoam (Seton Scholl)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Tielle (Johnson and Johnson)
Number of subjects: 6
Study: 8970187

Group type: EXPERIMENTAL
Intervention: Nitrous oxide [67% N2O‐33% O2 (vol/vol)]
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nitrous oxide [67% N2O‐33% O2 (vol/vol)] in orthopedic procedures
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (fasted for 10 hrs, no anesthesia)
Number of subjects: 14
Study: 7953035

Group type: EXPERIMENTAL
Intervention: Community Support Team (CST)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Generic CPN care
Number of subjects: 82
Study: 3591604

Group type: EXPERIMENTAL
Intervention: Serum cholesterol and triglyceride levels, HDL cholesterol, LDL cholesterol measurements
Number of subjects: 4524

Group type: EXPERIMENTAL
Intervention: Serum cholesterol and LDL to HDL cholesterol ratio
Number of subjects: 4524
Study: 29625599

Group type: EXPERIMENTAL
Intervention: Healthy School Start Plus intervention
Number of subjects: 352

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 352
Study: 28219315

Group type: EXPERIMENTAL
Intervention: Resident teaching as small group facilitators in the Patient Safety course
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Residents with small group facilitation training in Y3
Number of subjects: 184
Study: 25604688

Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) cyclocoagulation, group 1 (4 seconds duration)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) cyclocoagulation, group 2 (6 seconds duration)
Number of subjects: 52
Study: 23635614

Group type: EXPERIMENTAL
Intervention: Combined intervention with pulmonary recruitment maneuver and intraperitoneal normal saline infusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 21118366

Group type: EXPERIMENTAL
Intervention: Cinacalcet for 12 months
Number of subjects: 31
Study: 18923220

Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.5 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral ketamine (5 mg/kg)
Number of subjects: 20
Study: 16626607

Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg (n = 413)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Placebo (n = 106)
Number of subjects: 519
Study: 14664877

Group type: EXPERIMENTAL
Intervention: Video information in addition to the standard consultation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional consultation (no video)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Video information
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Video information and standard consultation
Number of subjects: 31
Study: 10793878

Group type: EXPERIMENTAL
Intervention: E2 1 mg/NETA 0.25 mg
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: E2 1 mg/NETA 0.5 mg
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 9387527

Group type: EXPERIMENTAL
Intervention: 3,4-dihydroxyacetophynone (DHAP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal pregnant controls
Number of subjects: 22

Group type: COMPARATOR
Intervention: PIH group
Number of subjects: 22
Study: 1435165

Group type: EXPERIMENTAL
Intervention: Salbutamol (2 puffs = 200 micrograms)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 7
Study: 4016829

Group type: EXPERIMENTAL
Intervention: Netilmicin-clindamycin
Number of subjects: 53

Group type: COMPARATOR
Intervention: Tobramycin-clindamycin
Number of subjects: 53
Study: 29705485

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 90

Group type: COMPARATOR
Intervention: Footbath
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study: 27287856

Group type: EXPERIMENTAL
Intervention: Erlotinib 85 mg/m2 daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Etoposide 50 mg/m2/day for 21 days
Number of subjects: 25
Study: 24888739

Group type: EXPERIMENTAL
Intervention: Single-dose Nevirapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional tests
Number of subjects: 0
Study: 22885982

Group type: EXPERIMENTAL
Intervention: VARIETY - four highly‐liked fruits served over 4, 7‐min courses
Number of subjects: 20

Group type: COMPARATOR
Intervention: NON‐VARIETY - participants received their most highly‐liked fruit (fruit 1) for each of the four courses
Number of subjects: 20
Study: 20594372

Group type: EXPERIMENTAL
Intervention: Subsidized artemisinin-based combination therapies (ACTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Shops stocking ACTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other antimalarial drugs
Number of subjects: 0
Study: 18238985

Group type: EXPERIMENTAL
Intervention: Surgical staging
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative imaging
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gross examination of depth of myometrial invasion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postoperative adjuvant pelvic radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conservative treatment for childbearing
Number of subjects: 0
Study: 15785909

Group type: EXPERIMENTAL
Intervention: C-loop haptics
Number of subjects: 50

Group type: COMPARATOR
Intervention: Z haptics
Number of subjects: 50
Study: 12571693

Group type: EXPERIMENTAL
Intervention: Administration of acetylsalicylic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Administration of beta-blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Administration of angiotensin-converting enzyme inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Administration of thrombolytics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Administration of statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mortality for AMI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Readmissions for AMI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Readmissions for unstable angina
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Readmissions for congestive heart failure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Median length of stay in the emergency department
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Median waiting times for cardiac catheterization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Median waiting times for percutaneous coronary intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Median waiting times for coronary artery bypass graft surgery
Number of subjects: 0
Study: 10491502

Group type: EXPERIMENTAL
Intervention: Effidrate cream (glycerol alkyl-ether) applied on one side of the face
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 20
Study: 8902681

Group type: EXPERIMENTAL
Intervention: Tx-1 = 1.0 MHz at 1.5 W/cm2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tx-2 = 1.0 MHz at 1.0 W/cm2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tx-5 = sham
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tx-3 = 3.0 MHz at 1.2 W/cm2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tx-4 = 3.0 MHz at 1.0 W/cm2
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 1671008

Group type: EXPERIMENTAL
Intervention: Propranolol-atropine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 0
Study: 7034932

Group type: EXPERIMENTAL
Intervention: PACE (cisplatin, doxorubicin, cyclophosphamide, and vindesine)
Number of subjects: 74

Group type: COMPARATOR
Intervention: PCE (cisplatin, cyclophosphamide, and vindesine)
Number of subjects: 74
Study: 31667661

Group type: EXPERIMENTAL
Intervention: Cre8
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Biomatrix
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Xience
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 60
Study: 30973204

Group type: EXPERIMENTAL
Intervention: Basal insulin-supported oral antidiabetic drugs therapy (BOT)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Oral antidiabetic drugs (OADs)
Number of subjects: 290
Study: 26923199

Group type: EXPERIMENTAL
Intervention: PATHS (Promoting Alternative Thinking Strategies) curriculum
Number of subjects: 568

Group type: COMPARATOR
Intervention: Usual practices (Control group)
Number of subjects: 568
Study: 25928515

Group type: EXPERIMENTAL
Intervention: Intrarectal ice application 5 minutes before procedure
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2% lidocaine gel 10 mL applied 10 minutes before procedure
Number of subjects: 120
Study: 23348933

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise at 30% of maximal contraction for 6-8 minutes
Number of subjects: 53
Study: 21465229

Group type: EXPERIMENTAL
Intervention: gemcitabine/paclitaxel
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: gemcitabine/carboplatin
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: gemcitabine/cisplatin
Number of subjects: 147

Group type: COMPARATOR
Intervention: Overall survival and progression-free survival
Number of subjects: 147
Study: 19734378

Group type: EXPERIMENTAL
Intervention: Laser acupuncture (830 nm, 10 mW, Ga-Al-As laser diode)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham laser
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Laser acupuncture
Number of subjects: 100
Study: 18209230

Group type: EXPERIMENTAL
Intervention: Leisure-time physical activity
Number of subjects: 3514

Group type: EXPERIMENTAL
Intervention: Motivation to change lifestyle behaviors
Number of subjects: 3514
Study: 15159318

Group type: EXPERIMENTAL
Intervention: Controlled diet with 5 servings (750 g) of fruits and vegetables daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Controlled diet with 2 servings (300 g) of fruits and vegetables daily
Number of subjects: 40
Study: 15142508

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Voriconazol
Number of subjects: 0
Study: 10427231

Group type: EXPERIMENTAL
Intervention: Complementary therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8528169

Group type: EXPERIMENTAL
Intervention: Interferon‐alpha post‐transplant
Number of subjects: 33

Group type: COMPARATOR
Intervention: Melphalan (200 mg/m2) and methylprednisolone (1.5 g x 5) for conditioning
Number of subjects: 33

Group type: COMPARATOR
Intervention: Higher levels of paraprotein (> 10 milligrams) at the time of transplant
Number of subjects: 33

Group type: COMPARATOR
Intervention: Patients who ultimately cleared paraprotein
Number of subjects: 33
Study: 2292631

Group type: EXPERIMENTAL
Intervention: Computer-assisted attention retraining program
Number of subjects: 29

Group type: COMPARATOR
Intervention: Memory training program (control)
Number of subjects: 29
Study: 7321973

Group type: EXPERIMENTAL
Intervention: Hydroalcoholic preparation (Brondecon elixir)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Alcohol-free preparation (Nuelin syrup)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison of both preparations
Number of subjects: 8
Study: 31658542

Group type: EXPERIMENTAL
Intervention: Micro-negative pressure treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Silver sulfadiazine cream with dressing change every other day
Number of subjects: 64
Study: 27925676

Group type: EXPERIMENTAL
Intervention: Carfilzomib at doses ranging from 15 to 20/56 mg/m2, administered as an intravenous infusion on 2 consecutive days each week for 3 weeks (days 1, 2, 8, 9, 15, and 16).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carfilzomib at 20/56 mg/m2 as a 30-minute infusion for monotherapy and combination therapy.
Number of subjects: 0
Study: 26888240

Group type: EXPERIMENTAL
Intervention: Combination of semilunar coronally advanced flap (SCAF) and button technique
Number of subjects: 12

Group type: COMPARATOR
Intervention: Semilunar coronally advanced flap (SCAF) alone
Number of subjects: 12